We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human heart.

Machine Learning Reveals Sex Disparities in Heart Disease Diagnosis

Coral reef.

Exploring the Use of Nature-Based Solutions for Healthy Corals and Communities

Microscopic image of a group of bacteria cells

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

Feedback Loop Melting West Antarctic Ice Sheet Uncovered

Pupil Dilation Correlates With Improved Working Memory

Probing the Inner World of Cells Provides Unexpected Boost to Prime Editing

News

Abide Therapeutics Announces Collaboration with Merck

Collaboration agreement to develop novel therapies for type 2 diabetes and metabolic diseases.

MorphoSys Announces Clinical Milestone in Ophthalmology Program

Company has received a milestone payment from Novartis.

ThromboGenics’ JETREA® Available in Germany Public and Private Market

Company could receive a further €210 million in milestones plus significant royalties.

Symphogen Expands Previous Private Equity Round, Reaching a Total of € 141 Million

Novo A/S and PKA led the expansion with investments of €20 million each, while Danica Pension participated with its pre-financing ownership share of the additional financing.

Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives

Intrexon Corporation announced that it has closed a Series F preferred investment round of $150 million, bringing the company’s total capital raised to $509 million.

Algeta Signs Exclusive License Agreement with Lumiphore, Inc.

Algeta ASA has exercised its option to take an exclusive, worldwide license to patented Lumi4® bi-functional chelator technology from Lumiphore, Inc.

Patent Litigation Settlement and License between Merck Millipore and W. L. Gore & Associates, Inc.

Merck Millipore announced the settlement of patent infringement disputes between Merck Millipore and W.L. Gore & Associates, Inc. in the United States.

Origenis Extends Collaboration and Licensing Agreement with Major Pharmaceutical Company

Collaboration and Licensing Agreement extended to optimize and transfer small molecule drugs for important therapeutic targets.

STEMCELL Technologies Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies

The agreement will enable STEMCELL Technologies to develop media that are optimized for cellular reprogramming.

Strategic Partnership Signals New Age of Stratified Medicine

Aridhia and Pivotal™ collaborating on revolutionary solutions for chronic disease management.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter